tirzepatide off the market (Zepbound) FDA says tirzepatide shortage is

[1] Any of these ingredients could potentially trigger a reaction in susceptible individuals

N Engl J Med 392(6):612615 Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

People with heart conditions need to think carefully about B12 supplements

Microdosing (18 months): 18 months $300 = $5,400 (saves $6,600)

From listening to thousands of patients with candida, Brain Fog best describes their difficulty concentrating on and remembering daily tasks